TREM1 is preferentially expressed by M2-like TAMs and induces a mesenchymal-like state in glioma stem cells (GSCs) by modulating the secretion of TGFβ2, thereby activating the TGFβR/SMAD2/3 signaling pathway in GSCs (33). Here, SMAD2 is linked to central nervous system cancer.